JEL-0305

N/A

Report date: 2024/10/30 17:12:30
NME

Base Information

Drug NameJEL-0305
Drug Alias NameJEL-0305JEL0305
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionMitogen-activated protein kinase inhibitors
TargetsMitogen-activated protein kinase
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCarocell Bio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCarocell Bio Ltd
Inactive CompaniesN/A
Active IndicationsDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A